Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

210 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Long working hours and skipping breakfast concomitant with late evening meals are associated with suboptimal glycemic control among young male Japanese patients with type 2 diabetes.
Azami Y, Funakoshi M, Matsumoto H, Ikota A, Ito K, Okimoto H, Shimizu N, Tsujimura F, Fukuda H, Miyagi C, Osawa S, Osawa R, Miura J. Azami Y, et al. Among authors: osawa s, osawa r. J Diabetes Investig. 2019 Jan;10(1):73-83. doi: 10.1111/jdi.12852. Epub 2018 May 30. J Diabetes Investig. 2019. PMID: 29667372 Free PMC article.
Establishment of porcine fecal-derived ex vivo microbial communities to evaluate the impact of livestock feed on gut microbiome.
Tsujikawa Y, Nishiyama K, Namai F, Imamura Y, Sakuma T, Saha S, Suzuki M, Sakurai M, Iwata R, Matsuo K, Takamori H, Suda Y, Zhou B, Fukuda I, Villena J, Sakane I, Osawa R, Kitazawa H. Tsujikawa Y, et al. Among authors: osawa r. Biosci Microbiota Food Health. 2024;43(2):100-109. doi: 10.12938/bmfh.2023-085. Epub 2023 Nov 15. Biosci Microbiota Food Health. 2024. PMID: 38577893 Free PMC article.
Effectiveness of primary series, first, and second booster vaccination of monovalent mRNA COVID-19 vaccines against symptomatic SARS-CoV-2 infections and severe diseases during the SARS-CoV-2 omicron BA.5 epidemic in Japan: vaccine effectiveness real-time surveillance for SARS-CoV-2 (VERSUS).
Maeda H, Saito N, Igarashi A, Ishida M, Terada M, Masuda S, Osawa R, Hosokawa N, Nakashima K, Kamura H, Imura H, Inoue H, Matsuzaka S, Sugimoto Y, Kuwamitsu O, Motohashi I, Morikawa T, Oda R, Hoshina Y, Matono T, Teshigahara O, Sando E, Asami S, Kudo S, Akizuki N, Muto Y, Hayakawa T, Kishaba T, Ohara Y, Kubo Y, Suzuki M, Morimoto K. Maeda H, et al. Among authors: osawa r. Expert Rev Vaccines. 2024 Jan-Dec;23(1):213-225. doi: 10.1080/14760584.2024.2310807. Epub 2024 Feb 8. Expert Rev Vaccines. 2024. PMID: 38288980 Free article.
210 results